Norepinephrine Dosage and Risk for Atrial Fibrillation in Septic Shock.

This article critiques a retrospective study by Narváez et al. that examined risk factors for new-onset atrial fibrillation in patients with sepsis and septic shock, focusing on the use of norepinephrine and vasopressin vasopressors. The critique emphasizes that the original study’s analysis, which considered only the presence of these vasopressors without accounting for their dosages, may lead to misleading conclusions about the association between dual vasopressor use and atrial fibrillation. It highlights that higher doses of norepinephrine, a catecholamine with β1-adrenergic effects, are linked to increased arrhythmia risk, and that vasopressin is typically used to reduce catecholamine exposure, potentially lowering atrial fibrillation incidence. The article recommends that future analyses incorporate norepinephrine dosage as a key variable when assessing vasopressor-related risks in septic shock. [Extracted from the article]